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etter to the Editorigh  frequency  of human  papillomavirus  type 53
n oral  cavity  of  asymptomatic  HIV-infected  people
ear Editor,
uman papillomavirus (HPV) has been associated with the
enign and malign diseases of the oral cavity, being con-
idered a cofactor in human immunodeﬁciency virus (HIV)
cquisition.1 Given the increased risk for HPV-associated oral
iseases in HIV-positive patients, screening of HPV in healthy
ral mucosa of these patients might be useful for epidemiol-
gy, preventive health measures, and treatment options.
In this way, we  conducted a descriptive, case–control study
n 197 individuals aged from 18 to 75 years and asymp-
omatic for oral lesions. The target group consisted of 77
IV-positive individuals who attended at the University Hos-
ital’s ambulatory, Niterói City, Rio de Janeiro, Brazil, between
009 and 2010. The control group included 120 volunteers
rom University Hospital’s blood donors service, located in the
Table 1 – Occurrence of oral HPV genotypes in HIV-positive and negative people.
HPV genotypes HPV genotypes frequency Odds ratio (95% CI) 2
HIV+ N (%) HIV−  N (%) p-Value
Low risk
6 11 (14.3) 33 (27.5) 0.43 (0.20–0.93) 0.021
11 6 (7.8) 0.0 1.08 (1.01–1.15) 0.003
13 1 (1.3) 0.0
72 0.0 1 (0.8)
High risk
18 1 (1.3) 1 (0.8)
52 0.0 1 (0.8)
Probable high risk
53 17 (22.1) 1 (0.8) 33.72 (4.38–259.4) 0.000
82 2 (2.6) 0.0
Undetermined risk
32 0.0 1 (0.8)
71 0.0 2 (1.7)
84 0.0 1 (0.8)
Beta-papillomavirus
110 1 (1.3) 0.0
same city. The Ethics Committee of the College of Medicine
of the University provided ethical clearance for the proto-
col and informed consent, under the registration 357.085.
Demographic and behavioral data were collected through a
structured questionnaire. For HIV-positive people, CD4 counts
were determined and plasma HIV-1 RNA levels were mea-
sured. An oral mucosal sample was harvested from all
participants. The DNA extracted was submitted to PCR assay
for HPV detection using MY09/11 consensus primers and HPV
positive samples were typiﬁed by restriction fragment length
polymorphism analysis (RFLP) or automated sequencing. A
databank was generated in the SPSS-18 statistical packet to
identify associations between variants and the presence of
HPV.
Regarding HIV infection status, 68.4% of patients had unde-
tectable HIV viral load, 76.6% reported HIV diagnostic more120 2 (2.6) 0.0
Co-infections 15 (89.1) 5 (10
Unidentiﬁed types 20 (26.0) 11 (9.
Negative samples 31 (40.3) 74 (61.9) 3.96 (1.30–12.09) 0.021
2) 3.47 (1.55–7.75) 0.002
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than 4 four years prior, and 88.3% were undergoing antiviral
therapy. At the time of our study, 90.9% of patients had above
200 CD4+ cells/mL. Demographic variables did not affect HPV
infection in HIV positive or negative people. However, oral HPV
infection was signiﬁcantly associated with HIV-positive indi-
viduals (59.7% versus 38.3%, p = 0.004). Table 1 displays the
spectrum of HPV genotypes found in oral cavity from both
populations. They are categorized according to the criterion
based on the risk for cervical cancer.2
HPV genotypes differed in HIV positive and negative peo-
ple, in spite of non oncogenic types have predominated in both
groups. The types that could not be identiﬁed by performed
techniques were signiﬁcantly higher in the group infected
with HIV, being three times higher in those who had received
HIV diagnosis less than 4 years prior (p = 0.045). It can be that
low immunity, yet not recovered by antiretroviral treatment,
has favored the acquisition of unidentiﬁed HPV genotypes.
A signiﬁcant association was found between HPV 53 and
HIV infection, and the risk for it in the women oral cavity
was about six times higher than in men  (p = 0.001). Concurrent
oral HPV infections were likely to be more  common in HIV-
positive patients than in the health individuals (Table 1). When
participants living or not with HIV infection were grouped to
evaluate these outcomes (N = 197), we  veriﬁed that women car-
ried out a signiﬁcant high percentage of multiple infections
(p = 0.005).
The signiﬁcant relationship between oral HPV 53 and HIV-
infected women must be considered. In a former study, our
research group detected HPV 53 among the most frequent
types found in cervical samples of HIV-infected women.3
Despite both studies may not be linked because they were
conducted with different HIV-infected populations, they point
out the HPV 53 prevalence in both oral and genital sites of the
HIV-infected women in a particular geographic area. Martins
et al.4 also reported the HPV 53 as the most frequently geno-
type among cervical scrapes from HIV-positive women in the
northeastern Brazil. In the same way, Palefsky et al.5 observed
in cervical samples among the HIV-positive women that some
low and probable risk HPV types, including HPV 53, were sig-
niﬁcantly more  common among those with lower CD4 levels,
and these also spanned the range of oncogenic risk. Therefore,
the results described in the present study could suggest a high
spread of HPV 53 genotype among HIV-infected population by
oral/genital transmission.
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